Interim laboratory biosafety guidelines for handling and processing specimens associated with Middle East Respiratory Syndrome
Published Date:June 7, 2013
Corporate Authors:Centers for Disease Control and Prevention (U.S.)
Keywords:Containment Of Biohazards/standards
Coronavirus Infections/prevention & Control
Infectious Disease Transmission, Patient-to-Professional/prevention & Control
Inhalation Exposure/prevention & Control
Middle East Respiratory Syndrome Coronavirus
Occupational Exposure/prevention & Control
Description:I. General guidelines (for working with potentially infectious materials) -- II. Specific guidelines -- III. Packing, shipping and transport.
To date, little is known about pathogenic potential and transmission dynamics of Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Until more information becomes available, precautions should be taken in collecting and handling specimens that may contain MERS-CoV.
Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible MERS-CoV infection. Such specimens should be labeled accordingly, and the laboratory should be alerted to ensure proper specimen handling. General and specific biosafety guidelines for handling MERS-CoV specimens are provided below.
Supporting Files:No Additional Files
You May Also Like: